A 52-year-old woman with a history of chronic kidney disease undergoes ultrasound for hypertension workup. A 2.5 cm hyperechoic mass is incidentally found in the left kidney. Ultrasound cannot definitively characterise it as benign or malignant. What is the most appropriate next investigation?

Question

Accepted Answer

C. Contrast-enhanced CT of abdomen and pelvis. ## Characterisation of Indeterminate Renal Mass

**Key Point:** When ultrasound cannot definitively characterise a renal mass as benign or malignant, **contrast-enhanced CT (CECT)** is the next best investigation because it reliably distinguishes solid tumours from cysts and characterises enhancement patterns.

### Diagnostic Algorithm for Indeterminate Renal Mass

```mermaid
flowchart TD
  A[Renal mass on ultrasound]:::outcome --> B{Clearly benign cyst?}:::decision
  B -->|Yes: simple cyst| C[No further imaging]:::action
  B -->|No: indeterminate| D[CECT abdomen/pelvis]:::action
  D --> E{Enhancement pattern?}:::decision
  E -->|No enhancement| F[Benign: likely oncocytoma/AML]:::outcome
  E -->|Arterial enhancement| G[Suspicious for RCC]:::urgent
  G --> H[Staging CECT + biopsy if needed]:::action
  E -->|Minimal enhancement| I[Likely benign: follow-up imaging]:::action
```

### Why CECT is Superior for Characterisation

| Feature | CECT | Renal Biopsy | MRI (no gadolinium) | Follow-up US |
|---------|------|--------------|---------------------|---------------|
| **Characterises mass** | Excellent (enhancement pattern) | Tissue diagnosis but invasive | Limited without contrast | Limited |
| **Detects enhancement** | Yes (arterial, venous, delayed) | N/A | No (no gadolinium) | No |
| **Distinguishes RCC from benign** | 95% sensitivity | 100% but invasive | Poor without contrast | Unreliable |
| **Risk of complications** | Contrast reaction, nephropathy | Bleeding, infection, seeding | None | Delayed diagnosis |
| **Cost-effective** | Yes | Expensive, invasive | Expensive | Delays diagnosis |

**High-Yield:** CECT enhancement patterns in renal masses:
- **RCC:** Arterial phase enhancement (>20 HU increase), washout in delayed phase
- **Oncocytoma:** Homogeneous enhancement, central scar (benign)
- **Angiomyolipoma (AML):** Fat density (−10 to −100 HU) on unenhanced CT — diagnostic
- **Simple cyst:** No enhancement, water density (0–20 HU)
- **Bosniak classification:** Grades cystic lesions I–IV; III/IV require follow-up or intervention

### Why Other Options Are Incorrect

**Renal biopsy:**
  - Invasive with risk of **bleeding, infection, and tumour seeding**
  - Reserved for:
    - Confirmation of diagnosis when imaging is equivocal AND management depends on it
    - Suspected metastatic disease to kidney
    - Evaluation of renal dysfunction (not applicable here)
  - NOT first-line for characterising an indeterminate mass

**MRI without gadolinium:**
  - Gadolinium is essential for characterising renal masses (contrast-enhanced MRI = CEMRI)
  - Non-contrast MRI provides no enhancement information and cannot reliably distinguish RCC from benign lesions
  - Delays diagnosis unnecessarily

**Follow-up ultrasound in 3 months:**
  - Ultrasound has poor specificity for characterising solid renal masses
  - Delays diagnosis of potentially malignant lesion
  - If mass is RCC, delay increases stage and reduces survival
  - Only appropriate for **clearly benign** cysts (Bosniak I) or in patients with contraindications to contrast

**Clinical Pearl:** A **2.5 cm hyperechoic mass** on ultrasound is suspicious for RCC (clear cell carcinoma often appears hyperechoic due to lipid content) or benign lesions (oncocytoma, AML). CECT will definitively characterise it:
  - If it enhances in arterial phase → likely RCC → proceed to staging and surgery
  - If it shows fat density → AML (benign) → conservative management
  - If it shows no enhancement → likely oncocytoma → follow-up imaging

**Mnemonic: CECT for indeterminate mass** = **C**haracterise, **E**nhancement pattern, **C**onfirm diagnosis, **T**reatment planning.

![Renal Cell Carcinoma diagram](https://mmcphlazjonnzmdysowq.supabase.co/storage/v1/object/public/blog-images/explanation/3148.webp)

Answer

A. Follow-up ultrasound in 3 months

Answer

B. MRI abdomen without gadolinium

Answer

D. Renal biopsy under ultrasound guidance

A 52-year-old woman with a history of chronic kidney disease undergoes ultrasound for hypertension workup. A 2.5 cm hyperechoic mass is incidentally found in the left kidney. Ultrasound cannot definitively characterise it as benign or malignant. What is the most appropriate next investigation?

Explanation

Characterisation of Indeterminate Renal Mass

Diagnostic Algorithm for Indeterminate Renal Mass

Why CECT is Superior for Characterisation

Why Other Options Are Incorrect

Practice similar questions

Join our NEET PG community

Feature	CECT	Renal Biopsy	MRI (no gadolinium)	Follow-up US
Characterises mass	Excellent (enhancement pattern)	Tissue diagnosis but invasive	Limited without contrast	Limited
Detects enhancement	Yes (arterial, venous, delayed)	N/A	No (no gadolinium)	No
Distinguishes RCC from benign	95% sensitivity	100% but invasive	Poor without contrast	Unreliable
Risk of complications	Contrast reaction, nephropathy	Bleeding, infection, seeding	None	Delayed diagnosis
Cost-effective	Yes	Expensive, invasive	Expensive	Delays diagnosis